Rey-Joly C - Search Results

1

[Evaluation of drug addicts with associated pathology. Clinical and therapeutic aspects of the integral attention].

Muga R, Guardiola H, Rey-Joly C. Muga R, et al. Med Clin (Barc). 2004 May 1;122(16):624-35. doi: 10.1016/s0025-7753(04)74332-8. Med Clin (Barc). 2004. PMID: 15142512 Review. Spanish.

2

[Gender and liver, nutritional and metabolic alterations of severe alcoholism: a study of 480 patients].

Sanvisens A, Rivas I, Bolao F, Tor J, Rosón B, Rey-Joly C, Muga R. Sanvisens A, et al. Among authors: rey joly c. Med Clin (Barc). 2011 Jun 11;137(2):49-54. doi: 10.1016/j.medcli.2010.11.030. Epub 2011 Mar 17. Med Clin (Barc). 2011. PMID: 21419462 Spanish.

3

[Dyslipemia and HIV-1 infection in intravenous drug addicts].

Muga R, Tor J, Rey-Joly C, Pardo A, Llobet P, Foz M. Muga R, et al. Med Clin (Barc). 1993 Feb 6;100(5):161-3. Med Clin (Barc). 1993. PMID: 8450692 Spanish.

4

[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset].

Egea JM, Tor J, Muga R, Roca J, Rodríguez R, Navío M, Rey-Joly C. Egea JM, et al. Med Clin (Barc). 1996 Jan 27;106(3):87-90. Med Clin (Barc). 1996. PMID: 8948942 Spanish.

5

[Immunoglobulin A and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts].

Muga R, Tor J, Solsona L, Villanueva C, Pol M, Jacas C, Sabriá M, Rey-Joly C, Foz M. Muga R, et al. Med Clin (Barc). 1991 Mar 16;96(10):361-3. Med Clin (Barc). 1991. PMID: 2046411 Spanish.

6

Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001.

Muga R, Sanvisens A, Bolao F, Tor J, Santesmases J, Pujol R, Tural C, Langohr K, Rey-Joly C, Muñoz A. Muga R, et al. Drug Alcohol Depend. 2006 Apr;82 Suppl 1:S29-33. doi: 10.1016/s0376-8716(06)80005-0. Drug Alcohol Depend. 2006. PMID: 16769442

7

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.

Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A. Muga R, et al. Clin Infect Dis. 2007 Aug 1;45(3):370-6. doi: 10.1086/519385. Epub 2007 Jun 19. Clin Infect Dis. 2007. PMID: 17599317 Free article.

8

Trends in human immunodeficiency virus infection among drug users in a detoxification unit.

Muga R, Sanvisens A, Egea JM, Tor J, Rey-Joly C. Muga R, et al. Clin Infect Dis. 2003 Dec 15;37 Suppl 5:S404-9. doi: 10.1086/377550. Clin Infect Dis. 2003. PMID: 14648455

9

Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy.

Fuster D, Planas R, Muga R, Ballesteros AL, Santos J, Tor J, Sirera G, Guardiola H, Salas A, Cabré E, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Tural C. Fuster D, et al. AIDS Res Hum Retroviruses. 2004 Dec;20(12):1293-7. doi: 10.1089/aid.2004.20.1293. AIDS Res Hum Retroviruses. 2004. PMID: 15650421

10

[Changes in cellular immunity in parenteral drug addicts].

Tor J, Juncá J, Muga R, Argelagués E, Rey-Joly C, Fox M, Ribas Mundó M. Tor J, et al. Med Clin (Barc). 1986 Jan 25;86(3):93-6. Med Clin (Barc). 1986. PMID: 3007887 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters